About 317,000 results
Open links in new tab
FDA approves Ebglyss for moderate-to-severe atopic dermatitis
Ebglyss Approved for Moderate to Severe Atopic Dermatitis
Ebglyss, a New Biologic Treatment for Atopic Dermatitis, Gets …
Aclaris doses first subject in Phase IIa atopic dermatitis trial
New Biologic for Atopic Dermatitis Receives FDA-Approval
New Treatment for Moderate to Severe Atopic Dermatitis Shows …
Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis
Treatment of Moderate to Severe Atopic Dermatitis: Highlights …
FDA approves new eczema drug Dupixent | FDA - U.S. Food and …
Atopic dermatitis: an expanding therapeutic pipeline for a …